share_log

12 Health Care Stocks Moving In Thursday's After-Market Session

Benzinga ·  Sep 27 04:31

Gainers

  • Cardio Diagnostics Hldgs (NASDAQ:CDIO) stock increased by 16.8% to $0.29 during Thursday's after-market session. The company's market cap stands at $6.9 million.
  • TC BioPharm (Holdings) (NASDAQ:TCBP) stock rose 6.69% to $6.16. The market value of their outstanding shares is at $3.1 million.
  • Seres Therapeutics (NASDAQ:MCRB) shares moved upwards by 6.01% to $0.88. The company's market cap stands at $134.0 million.
  • Chromocell Therapeutics (AMEX:CHRO) shares moved upwards by 5.88% to $1.08. The company's market cap stands at $6.2 million.
  • BioVie (NASDAQ:BIVI) stock moved upwards by 5.4% to $1.17. The company's market cap stands at $7.1 million.
  • China Pharma Holdings, Inc. Common Stock (AMEX:CPHI) stock rose 5.2% to $0.26.

Losers

  • Cue Biopharma (NASDAQ:CUE) shares decreased by 27.8% to $0.33 during Thursday's after-market session. The company's market cap stands at $15.9 million.
  • enVVeno Medical (NASDAQ:NVNO) stock declined by 15.34% to $3.81. The market value of their outstanding shares is at $50.7 million.
  • Telesis Bio (NASDAQ:TBIO) stock decreased by 7.04% to $3.7. The market value of their outstanding shares is at $6.5 million.
  • Streamline Health Solns (NASDAQ:STRM) shares declined by 6.17% to $0.21. The company's market cap stands at $13.3 million.
  • Lipella Pharmaceuticals (NASDAQ:LIPO) stock fell 5.38% to $0.48. The market value of their outstanding shares is at $3.8 million.
  • Travere Therapeutics (NASDAQ:TVTX) shares declined by 5.12% to $14.27. The market value of their outstanding shares is at $1.0 billion.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment